ALZcure is pioneering blockchain-powered funding for Alzheimer's research through Decentralized Science (DeSci). Built on ...

An experimental treatment appears to postpone Alzheimer's symptoms in some people genetically destined to get the disease at ...

Since becoming only the second Alzheimer's-modifying drug to gain American Federal Drug Administration approval in 2023, ...

New Mexico has paired up with the Alzheimer's Association in a pilot U.S. initiative aimed at raising awareness about a ...

A groundbreaking peer-reviewed Thought Leaders Invited Review article in Brain Medicine (Genomic Press, New York) explores how CD2-associated protein (CD2AP) contributes to Alzheimer's disease (AD), ...

One way to detect Alzheimer’s early is by spotting changes to people’s use of language. This is because new speech problems ...

Research announced today is the first of its kind to suggest that anti-amyloid drugs can delay or even stop the progression of symptoms in people with early-onset Alzheimer's.

Researchers have detailed the precise mechanism through which the inflammatory signaling molecule IL-12 contributes to Alzheimer's disease.

Planned single, pivotal Phase 2/3 clinical trial, if positive, acceptable for Biological License Application (BLA) submission for Alzheimer’s ...

Blueshirts will Honor the Franchise’s Centennial Year Throughout the Upcoming 2025-26 Regular Season, Celebrating the Club’s ...

Imagine spotting the signs of Alzheimer's a decade before it takes hold. A groundbreaking study hints at a surprising link ...

For decades, the United States has led the world in pharmaceutical innovation – developing drugs that combat cancer, heart ...